This inventor holds 1 USPTO granted patent. Top assignee: Repligen Corporation. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Deborah Brewer: Innovator in Uridine Therapy
Introduction
Deborah Brewer is a notable inventor based in Bethesda, MA (US). She has made significant contributions to the field of medical therapy, particularly in the treatment of patients with elevated purine levels. Her innovative approach has the potential to improve the lives of individuals diagnosed with various disorders.
Latest Patents
Deborah Brewer holds a patent for her invention titled "Uridine therapy for patients with elevated purine levels." This invention is based on the discovery that patients with elevated purine levels, such as those diagnosed with pervasive developmental disorders like autistic disorder and neuromuscular disorders, can benefit from uridine compositions. This groundbreaking work has the potential to offer new treatment options for affected individuals.
Career Highlights
Deborah Brewer is currently associated with Repligen Corporation, where she continues to advance her research and development efforts. Her work at the company reflects her commitment to innovation in the medical field. With a focus on improving patient outcomes, she has established herself as a key figure in her area of expertise.
Collaborations
Throughout her career, Deborah has collaborated with esteemed colleagues, including Charles D. Moseley and Theodore M. Page. These partnerships have contributed to the advancement of her research and the successful development of her patented therapies.
Conclusion
Deborah Brewer's contributions to uridine therapy represent a significant advancement in the treatment of patients with elevated purine levels. Her innovative work continues to inspire and pave the way for future research in this important area of medicine.